| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Sullivan Louis W is a Director at Emergent BioSolutions Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 24 sells.
Estimated insider holdings value: $4.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 26, 2022 | UTHR United Therapeutics Corp | Director | Sale+OE | 6,310 | $225.00 | $1,419,781.45 | -10.6% | -1.0% | -7.8% | |
| Sep 2, 2020 | EBS Emergent Biosolutions Inc. | Director | Sale+OE | 28,418 | $111.22 | $3,160,605.90 | -24.9% | - | - | |
| Mar 4, 2020 | EBS Emergent Biosolutions Inc. | Director | Sale+OE | 15,786 | $58.96 | $930,714.15 | -11.5% | - | - | |
| May 13, 2016 | EBS Emergent Biosolutions Inc. | Director | Sale+OE | 47,631 | $39.21 | $1,867,761.00 | -29.5% | - | - | |
| May 11, 2016 | EBS Emergent Biosolutions Inc. | Director | Sale+OE | 9,969 | $39.25 | $391,283.25 | -25.9% | - | - | |
| Mar 11, 2016 | EBS Emergent Biosolutions Inc. | Director | Sale+OE | 14,879 | $34.03 | $506,332.37 | -34.3% | - | - | |
| Mar 10, 2016 | EBS Emergent Biosolutions Inc. | Director | Sale+OE | 14,820 | $35.34 | $523,738.80 | -34.2% | - | - | |
| Mar 2, 2016 | HSIC Henry Schein Inc | Director | Sale+OE | 11,735 | $168.59 | $1,978,374.24 | -31.1% | - | - | |
| Nov 17, 2015 | HSIC Henry Schein Inc | Director | Sale+OE | 15,622 | $154.13 | $2,407,750.16 | -11.8% | - | - | |
| Jun 16, 2015 | EBS Emergent Biosolutions Inc. | Director | Sale+OE | 13,457 | $31.32 | $421,540.52 | -32.1% | - | - |